These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 22568565
1. Noradrenaline use for septic shock in children: doses, routes of administration and complications. Lampin ME, Rousseaux J, Botte A, Sadik A, Cremer R, Leclerc F. Acta Paediatr; 2012 Sep; 101(9):e426-30. PubMed ID: 22568565 [Abstract] [Full Text] [Related]
2. Noradrenaline for management of septic shock refractory to fluid loading and dopamine or dobutamine in full-term newborn infants. Tourneux P, Rakza T, Abazine A, Krim G, Storme L. Acta Paediatr; 2008 Feb; 97(2):177-80. PubMed ID: 18177443 [Abstract] [Full Text] [Related]
3. Refractory septic shock: efficacy and safety of very high doses of norepinephrine. Katsaragakis S, Kapralou A, Theodorou D, Markogiannakis H, Larentzakis A, Stamou KM, Drimousis P, Bramis I. Methods Find Exp Clin Pharmacol; 2006 Jun; 28(5):307-13. PubMed ID: 16845448 [Abstract] [Full Text] [Related]
4. Terlipressin facilitates transport of septic patients treated with norepinephrine. Klein M, Weksler N, Borer A, Koyfman L, Kesslin J, Gurman GM. Isr Med Assoc J; 2006 Oct; 8(10):691-3. PubMed ID: 17125115 [Abstract] [Full Text] [Related]
5. [Effect of dopamine combined with norepinephrine on the renal function in patients with septic shock]. Hou LC, Ji GL, Xiong LZ, Chen SY, Chen M, Huo TT, Hu WN, Wang YL, Wang C, Bai XG. Zhonghua Wai Ke Za Zhi; 2006 Sep 01; 44(17):1206-8. PubMed ID: 17147869 [Abstract] [Full Text] [Related]
6. Comparative Effectiveness of Second Vasoactive Agents in Septic Shock Refractory to Norepinephrine. Nguyen HB, Lu S, Possagnoli I, Stokes P. J Intensive Care Med; 2017 Aug 01; 32(7):451-459. PubMed ID: 27189952 [Abstract] [Full Text] [Related]
7. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR, Glaxo Wellcome International Septic Shock Study Group. Crit Care Med; 2004 Jan 01; 32(1):13-20. PubMed ID: 14707555 [Abstract] [Full Text] [Related]
8. Impact of Norepinephrine Weight-Based Dosing Compared With Non-Weight-Based Dosing in Achieving Time to Goal Mean Arterial Pressure in Obese Patients With Septic Shock. Vadiei N, Daley MJ, Murthy MS, Shuman CS. Ann Pharmacother; 2017 Mar 01; 51(3):194-202. PubMed ID: 27886982 [Abstract] [Full Text] [Related]
9. [Noradrenaline in the "high output-low resistance" state of patients with abdominal sepsis]. Redl-Wenzl EM, Armbruster C, Edelmann G, Fischl E, Kolacny M, Wechsler-Fördös A, Sporn P. Anaesthesist; 1990 Oct 01; 39(10):525-9. PubMed ID: 2278372 [Abstract] [Full Text] [Related]
10. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study). Póvoa PR, Carneiro AH, Ribeiro OS, Pereira AC, Portuguese Community-Acquired Sepsis Study Group. Crit Care Med; 2009 Feb 01; 37(2):410-6. PubMed ID: 19114885 [Abstract] [Full Text] [Related]
11. Glibenclamide dose response in patients with septic shock: effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport. Morelli A, Lange M, Ertmer C, Broeking K, Van Aken H, Orecchioni A, Rocco M, Bachetoni A, Traber DL, Landoni G, Pietropaoli P, Westphal M. Shock; 2007 Nov 01; 28(5):530-5. PubMed ID: 17589379 [Abstract] [Full Text] [Related]
12. Noradrenaline as a vasoactive agent in septic shock. Tordoff SG, Thompson JL, Williams AW. Intensive Care Med; 2000 May 01; 26(5):648. PubMed ID: 10923747 [No Abstract] [Full Text] [Related]
13. Noradrenaline use is not associated with extubation failure in septic patients. Teixeira C, Frederico Tonietto T, Cadaval Gonçalves S, Viegas Cremonese R, Pinheiro de Oliveira R, Savi A, Silvestre Oliveira E, André Cardona Alves F, Fernando Monteiro Brodt S, Hervê Diel Barth J, Santana Machado A, de Campos Balzano P, Gasparetto Maccari J, Brandão Da Silva N. Anaesth Intensive Care; 2008 May 01; 36(3):385-90. PubMed ID: 18564800 [Abstract] [Full Text] [Related]
14. [Possible induction to mistake in the dilution of noradrenaline]. Taberner Bonastre P, García Muñoz S, Soriano Clemente A, Soler Company E. Farm Hosp; 2013 May 01; 37(6):558-9. PubMed ID: 24256020 [No Abstract] [Full Text] [Related]
15. Early suspension of activated protein C treatment in septic patients after shock reversal. Pestaña D, Ramos R. Eur J Anaesthesiol; 2009 Dec 01; 26(12):1072-5. PubMed ID: 19474736 [Abstract] [Full Text] [Related]
16. [Effects of noradrenaline therapy on gastrointestinal function in septic patients]. Wang YL, Wang YJ, Xing YB, Li C. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Jan 01; 15(1):42. PubMed ID: 12852816 [No Abstract] [Full Text] [Related]
17. Norepinephrine in low to moderate doses may not increase luminal concentrations of L-lactate in the gut in patients with septic shock. Ibsen M, Jørgensen VL, Perner A. Acta Anaesthesiol Scand; 2007 Sep 01; 51(8):1079-84. PubMed ID: 17697303 [Abstract] [Full Text] [Related]
18. Vasopressor use in septic shock: an update. Leone M, Martin C. Curr Opin Anaesthesiol; 2008 Apr 01; 21(2):141-7. PubMed ID: 18443479 [Abstract] [Full Text] [Related]
19. Use of heptaminol hydrochloride for catecholamine weaning in septic shock. Bahloul M, Chaari A, Ben Mbarek MN, Kallel H, Bouaziz M. Am J Ther; 2012 Jan 01; 19(1):e8-17. PubMed ID: 20720484 [Abstract] [Full Text] [Related]
20. Management of septic shock with a norepinephrine-based haemodynamic algorithm. Hernandez G, Bruhn A, Romero C, Javier Larrondo F, De La Fuente R, Castillo L, Bugedo G. Resuscitation; 2005 Jul 01; 66(1):63-9. PubMed ID: 15993731 [Abstract] [Full Text] [Related] Page: [Next] [New Search]